157 related articles for article (PubMed ID: 32631525)
1. Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.
Giri R; Namballa HK; Sarker A; Alberts I; Harding WW
Bioorg Med Chem Lett; 2020 Aug; 30(16):127305. PubMed ID: 32631525
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationship Studies on 6-Chloro-1-phenylbenzazepines Leads to the Identification of a New Dopamine D1 Receptor Antagonist.
Giri R; Namballa HK; Emogaje V; Harding WW
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630262
[TBL] [Abstract][Full Text] [Related]
3. Further studies on C2'-substituted 1-phenylbenzazepines as dopamine D1 receptor ligands.
Giri R; Namballa HK; Sarker A; Alberts I; Harding WW
Bioorg Chem; 2022 Oct; 127():105953. PubMed ID: 35772367
[TBL] [Abstract][Full Text] [Related]
4. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
5. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.
Wu WL; Burnett DA; Spring R; Greenlee WJ; Smith M; Favreau L; Fawzi A; Zhang H; Lachowicz JE
J Med Chem; 2005 Feb; 48(3):680-93. PubMed ID: 15689153
[TBL] [Abstract][Full Text] [Related]
7. (+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Izenwasser S; Geter-Douglass B; Witkin JM; Newman AH
J Med Chem; 1995 Oct; 38(21):4284-93. PubMed ID: 7473556
[TBL] [Abstract][Full Text] [Related]
8. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines.
Neumeyer JL; Kula NS; Bergman J; Baldessarini RJ
Eur J Pharmacol; 2003 Aug; 474(2-3):137-40. PubMed ID: 12921854
[TBL] [Abstract][Full Text] [Related]
9. (+/-)-3-allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship.
Baindur N; Tran M; Niznik HB; Guan HC; Seeman P; Neumeyer JL
J Med Chem; 1992 Jan; 35(1):67-72. PubMed ID: 1531075
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
Zhang J; Chen X; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
[TBL] [Abstract][Full Text] [Related]
11. Functional differentiation of multiple dopamine D1-like receptors by NNC 01-0012.
Sugamori KS; Hamadanizadeh SA; Scheideler MA; Hohlweg R; Vernier P; Niznik HB
J Neurochem; 1998 Oct; 71(4):1685-93. PubMed ID: 9751203
[TBL] [Abstract][Full Text] [Related]
12. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
[TBL] [Abstract][Full Text] [Related]
13. Functional reversal of (-)-Stepholidine analogues by replacement of benzazepine substructure using the ring-expansion strategy.
Li W; Zhang L; Xu L; Yuan C; Du P; Chen J; Zhen X; Fu W
Chem Biol Drug Des; 2016 Oct; 88(4):599-607. PubMed ID: 27232055
[TBL] [Abstract][Full Text] [Related]
14. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Celestini P; Damiani F; Di Fabio R; Donati D; Gagliardi S; Gentile G; Hamprecht D; Petrone M; Radaelli S; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):901-7. PubMed ID: 18248991
[TBL] [Abstract][Full Text] [Related]
15. The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport.
Gildea JJ; Shah IT; Van Sciver RE; Israel JA; Enzensperger C; McGrath HE; Jose PA; Felder RA
Kidney Int; 2014 Jul; 86(1):118-26. PubMed ID: 24552847
[TBL] [Abstract][Full Text] [Related]
16. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Damiani F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Perini O; Petrone M; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):908-12. PubMed ID: 18178090
[TBL] [Abstract][Full Text] [Related]
17. Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonists.
Qiang L; Sasikumar TK; Burnett DA; Su J; Tang H; Ye Y; Mazzola RD; Zhu Z; McKittrick BA; Greenlee WJ; Fawzi A; Smith M; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2010 Feb; 20(3):836-40. PubMed ID: 20061148
[TBL] [Abstract][Full Text] [Related]
18. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex.
Zenko M; Zhu Y; Dremencov E; Ren W; Xu L; Zhang X
J Neurosci Res; 2011 Aug; 89(8):1245-58. PubMed ID: 21557291
[TBL] [Abstract][Full Text] [Related]
19. Remote functionalization of SCH 39166: discovery of potent and selective benzazepine dopamine D1 receptor antagonists.
Sasikumar TK; Burnett DA; Greenlee WJ; Smith M; Fawzi A; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2010 Feb; 20(3):832-5. PubMed ID: 20064718
[TBL] [Abstract][Full Text] [Related]
20. Design and discovery of 1,3-benzodiazepines as novel dopamine antagonists.
Zhu Z; Sun ZY; Ye Y; McKittrick B; Greenlee W; Czarniecki M; Fawzi A; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2009 Sep; 19(17):5218-21. PubMed ID: 19643610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
